Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer.
- Published in:
- Prostate, 2010, v. 70, n. 2, p. 206, doi. 10.1002/pros.21054
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2010 AND VI 70 AND IP 2
Results: 13
1
2
p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2.
- Published in:
- Prostate, 2010, v. 70, n. 2, p. 126, doi. 10.1002/pros.21044
- By:
- Publication type:
- Article
3
Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expression.
- Published in:
- Prostate, 2010, v. 70, n. 2, p. 219, doi. 10.1002/pros.21055
- By:
- Publication type:
- Article
4
No association between variant DNA repair genes and prostate cancer risk among men of African descent.
- Published in:
- Prostate, 2010, v. 70, n. 2, p. 113, doi. 10.1002/pros.21048
- By:
- Publication type:
- Article
5
SRD5A2 V89L polymorphism and prostate cancer risk: A meta-analysis.
- Published in:
- Prostate, 2010, v. 70, n. 2, p. 170, doi. 10.1002/pros.21050
- By:
- Publication type:
- Article
6
Bone metabolic disorder in patients with prostate cancer receiving androgen deprivation therapy (ADT): impact of ADT on the growth hormone/insulin-like growth factor-1/parathyroid hormone axis.
- Published in:
- Prostate, 2010, v. 70, n. 2, p. 155, doi. 10.1002/pros.21047
- By:
- Publication type:
- Article
7
Radical prostatectomy: Influence on serum and urinary androgen levels.
- Published in:
- Prostate, 2010, v. 70, n. 2, p. 200, doi. 10.1002/pros.21053
- By:
- Publication type:
- Article
8
Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Purα-mediated decrease in androgen receptor levels.
- Published in:
- Prostate, 2010, v. 70, n. 2, p. 179, doi. 10.1002/pros.21051
- By:
- Publication type:
- Article
9
PSA and body composition by dual X-Ray absorptiometry (DXA) in NHANES.
- Published in:
- Prostate, 2010, v. 70, n. 2, p. 120, doi. 10.1002/pros.21039
- By:
- Publication type:
- Article
10
Tumor suppressor PAX6 functions as androgen receptor Co-repressor to inhibit prostate cancer growth.
- Published in:
- Prostate, 2010, v. 70, n. 2, p. 190, doi. 10.1002/pros.21052
- By:
- Publication type:
- Article
11
PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulators.
- Published in:
- Prostate, 2010, v. 70, n. 2, p. 135, doi. 10.1002/pros.21045
- By:
- Publication type:
- Article
12
Ets-1 and hypoxia inducible factor-1α inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.
- Published in:
- Prostate, 2010, v. 70, n. 2, p. 162, doi. 10.1002/pros.21049
- By:
- Publication type:
- Article
13
Prolongation of off-cycle interval by finasteride is not associated with survival improvement in intermittent androgen deprivation therapy in LNCaP tumor model.
- Published in:
- Prostate, 2010, v. 70, n. 2, p. 147, doi. 10.1002/pros.21046
- By:
- Publication type:
- Article